A high rate of combined hormonal contraceptive use was observed in reproductive age women with a medical contraindication to estrogen use, and these women may be at increased risk for cardiovascular events. This according to study of 987 adult women (46% aged 18 to 25 years) who were mostly white, employed, and married or cohabiting. Researchers found:
• 13% had a medical contraindication to estrogen-containing contraceptive use; migraine with aura (81%) was the most common, followed by hypertension (11%), smokers over age 35 (7%), history of VTE (4%), and diabetes with complications (2%).
• High use of combined hormonal contraceptives was reported among the women with medical contraindications to estrogen at 39%; however, this was not statistically different from women without a medical contraindication (47%).
• Among the women with a contraindication, whether they did or did not use an estrogen-containing contraceptive did not vary by education level, income, or weight.
Citation: Lauring JR, Lehman EB, Deimling TA, Legro RS, Chuang CH. Combined hormonal contraception use in reproductive age women with contraindications to estrogen use. [Published online ahead of print April 5, 2016]. Am J Obstet Gynecol. doi:http://dx.doi.org/10.1016/j.ajog.2016.03.047.
This Week's Must Reads
Must Reads in Contraception
Bleeding and Spotting with the LNG 13.5 mg IUS, Contraception; ePub 2019 Mar 1; Shimoni, et al
Contraception and Chronic Opioid Prescriptions, Contraception; ePub 2019 Feb 11; Ray-Griffith, et al
Hormonal Contraception & Coexisting Medical Conditions, Obstet Gynecol; ePub 2019 Feb; Allen, et al
Contraceptive Switching & Discontinuation, Am J Obstet Gynecol; ePub 2018 Dec 18; Simmons, et al
Efficacy of a Levonorgestrel 52-mg IU System, Obstet Gynecol; ePub 2018 Dec 4; Teal, et al